James Gallagher, BBC Health correspondent, experiences firsthand what a hot flush feels like while investigating emerging treatments for menopause symptoms. The report explores the physical sensation of sudden heat and perspiration that affects millions of women globally, particularly during perimenopause and menopause when estrogen levels decline.
Hot flushes disrupt sleep, work, and daily life for roughly 80 percent of menopausal women. Traditional hormone replacement therapy (HRT) remains the gold standard treatment, yet many women avoid it due to perceived health risks or personal preference. The landscape has shifted in recent years as new medications enter the market to address this gap.
Newer pharmacological options now include non-hormonal alternatives. Selective serotonin reuptake inhibitors (SSRIs) like paroxetine carry FDA approval for vasomotor symptoms. Venlafaxine, an SNRI, also demonstrates efficacy in clinical trials. These drugs work by regulating neurotransmitters that control blood vessel dilation and body temperature regulation.
Gallagher's hands-on reporting underscores a broader shift in how medicine approaches menopause. For decades, the condition remained medicalized yet understudied. Recent years have brought increased investment in menopause research and treatment development, driven by both patient advocacy and pharmaceutical innovation.
The BBC investigation reflects growing cultural conversation around menopause. Previously treated as inevitable and unworthy of medical attention, menopause now registers as a legitimate health concern deserving treatment options tailored to individual needs and preferences.
THE TAKEAWAY: New non-hormonal treatments expand menopause care beyond traditional HRT, addressing a symptom that affects the majority of women entering midlife.